• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BOT

BOTANIX PHARMACEUTICALS LTD - Announcements

1.67% ! 14.8¢
Market Cap $289.2M  !

Botanix (ASX:BOT) is an ASX-listed dermatology company based in Philadelphia and Phoenix... Botanix (ASX:BOT) is an ASX-listed dermatology company based in Philadelphia and Phoenix (USA), committed to the development of novel treatments for common skin diseases and infections.More

Announcements



Filters [Clear]
  • Price Sensitive: Yes
BOT New Antimicrobial Data and Conference PresentationPRICE SENSITIVE08/09/20 download Created with Sketch. 1.73MB
BOT Appendix 4E and Annual Report to ShareholdersPRICE SENSITIVE31/08/20 download Created with Sketch. 1.01MB
BOT BTX 1801 Phase 2a Antimicrobial Study UnderwayPRICE SENSITIVE12/08/20 download Created with Sketch. 187.59KB
BOT Appendix 4C - QuarterlyPRICE SENSITIVE30/07/20 download Created with Sketch. 326.32KB
BOT Response to ASX Aware QueryPRICE SENSITIVE22/07/20 download Created with Sketch. 740.97KB
BOT BTX 1503 End of Phase 2 Milestone with FDAPRICE SENSITIVE17/07/20 download Created with Sketch. 160.69KB
BOT Appendix 4C - QuarterlyPRICE SENSITIVE30/04/20 download Created with Sketch. 303.6KB
BOT FDA Grants BTX 1801 QIDP Designation StatusPRICE SENSITIVE24/04/20 download Created with Sketch. 275.59KB
BOT Botanix Provides Update on Development Activities AmendedPRICE SENSITIVE16/04/20 download Created with Sketch. 300.12KB
BOT Botanix Provides Update on Development ActivitiesPRICE SENSITIVE16/04/20 download Created with Sketch. 243.29KB
BOT Botanix Announces Top Line BTX 1204 Atopic Dermatitis DataPRICE SENSITIVE25/03/20 download Created with Sketch. 218.13KB
BOT Trading HaltPRICE SENSITIVE24/03/20 download Created with Sketch. 215.48KB
BOT Antimicrobial Platform Update and Launch of BTX 1801 StudyPRICE SENSITIVE13/03/20 download Created with Sketch. 5.77MB
BOT Half Yearly Report and AccountsPRICE SENSITIVE28/02/20 download Created with Sketch. 925.03KB
BOT Appendix 4C - QuarterlyPRICE SENSITIVE31/01/20 download Created with Sketch. 380KB
BOT Botanix Initiates BTX 1702 Rosacea StudyPRICE SENSITIVE09/12/19 download Created with Sketch. 160.86KB
BOT Botanix Announces De-scheduling of Synthetic CBDPRICE SENSITIVE25/11/19 download Created with Sketch. 505.76KB
BOT Appendix 4C - QuarterlyPRICE SENSITIVE31/10/19 download Created with Sketch. 382.3KB
BOT Botanix Announces BTX 1503 Data and Progression to Phase 3PRICE SENSITIVE22/10/19 download Created with Sketch. 739.31KB
BOT Trading HaltPRICE SENSITIVE22/10/19 download Created with Sketch. 359.17KB
BOT BOT Receives Grant for Synthetic Cannabidiol Analog ProgramPRICE SENSITIVE15/10/19 download Created with Sketch. 722.19KB
BOT Botanix announces new clinical program to target rosaceaPRICE SENSITIVE16/09/19 download Created with Sketch. 898.27KB
BOT Appendix 4E and Annual ReportPRICE SENSITIVE20/08/19 download Created with Sketch. 1022.01KB
BOT Botanix $40 Million US Lead Placement and Management UpdatePRICE SENSITIVE01/08/19 download Created with Sketch. 193.2KB
BOT Appendix 4C - QuarterlyPRICE SENSITIVE31/07/19 download Created with Sketch. 397.02KB
BOT Trading HaltPRICE SENSITIVE30/07/19 download Created with Sketch. 360.81KB
BOT Botanix Antimicrobial Platform Addresses Global ThreatPRICE SENSITIVE15/07/19 download Created with Sketch. 271.04KB
BOT BTX 1801 Kills Superbugs Without Resistance World-FirstPRICE SENSITIVE20/06/19 download Created with Sketch. 229.76KB
BOT Study Confirms Anti-inflammatory and Other Properties of CBDPRICE SENSITIVE19/06/19 download Created with Sketch. 866.27KB
BOT Trading HaltPRICE SENSITIVE18/06/19 download Created with Sketch. 242.68KB
BOT Pause in TradePRICE SENSITIVE18/06/19 download Created with Sketch. 118.21KB
BOT Dermatology Industry Leader Joins BotanixPRICE SENSITIVE20/05/19 download Created with Sketch. 504.05KB
BOT Botanix Provides Retraction in PresentationPRICE SENSITIVE16/05/19 download Created with Sketch. 470.8KB
BOT Trading HaltPRICE SENSITIVE16/05/19 download Created with Sketch. 242.55KB
BOT Pause In TradingPRICE SENSITIVE16/05/19 download Created with Sketch. 117.85KB
BOT Appendix 4C - QuarterlyPRICE SENSITIVE30/04/19 download Created with Sketch. 375.19KB
BOT Half Yearly Report and AccountsPRICE SENSITIVE28/02/19 download Created with Sketch. 390.01KB
BOT Permetrex Outperforms Other CBD Topical ProductsPRICE SENSITIVE26/02/19 download Created with Sketch. 8.72MB
BOT Appendix 4C - QuarterlyPRICE SENSITIVE31/01/19 download Created with Sketch. 839.2KB
BOT Investigators Meeting Completed for BTX 1204 Phase 2 StudyPRICE SENSITIVE25/01/19 download Created with Sketch. 178.7KB
BOT Ethics Approval for Phase 2 Atopic Dermatitis Study ReceivedPRICE SENSITIVE18/12/18 download Created with Sketch. 177.02KB
BOT Botanix receives A$4.6m R&D Tax Incentive refundPRICE SENSITIVE23/11/18 download Created with Sketch. 151.28KB
BOT First Patient Treated in BTX 1308 Psoriasis Patient StudyPRICE SENSITIVE07/11/18 download Created with Sketch. 197.52KB
BOT Appendix 4C - QuarterlyPRICE SENSITIVE31/10/18 download Created with Sketch. 350.81KB
BOT Ethics Approval for BTX 1308 Psoriasis Patient Study SecuredPRICE SENSITIVE27/09/18 download Created with Sketch. 106.68KB
BOT Botanix BTX 1503 Clinical Trial UpdatePRICE SENSITIVE12/09/18 download Created with Sketch. 151.01KB
BOT Pause in tradingPRICE SENSITIVE12/09/18 download Created with Sketch. 117.1KB
BOT Preliminary Final ReportPRICE SENSITIVE31/08/18 download Created with Sketch. 258.87KB
BOT FDA Clears Development Path for BTX 1204PRICE SENSITIVE30/08/18 download Created with Sketch. 131.96KB
BOT Appendix 4C - QuarterlyPRICE SENSITIVE31/07/18 download Created with Sketch. 590.1KB
BOT Investigators Meeting Completed for BTX 1503 Phase 2 TrialPRICE SENSITIVE23/07/18 download Created with Sketch. 111.27KB
BOT Botanix Joins with UQ to Accelerate Development of BTX 1801PRICE SENSITIVE19/07/18 download Created with Sketch. 207.21KB
BOT Botanix update on development pipeline productsPRICE SENSITIVE02/07/18 download Created with Sketch. 937.48KB
BOT First Patients Recruited into BTX 1503 Phase 2 Acne TrialPRICE SENSITIVE27/06/18 download Created with Sketch. 110.99KB
BOT BOT Welcomes First FDA Approval for Cannabidiol ProductPRICE SENSITIVE26/06/18 download Created with Sketch. 139.87KB
BOT Botanix Raises A$8m in Oversubscribed PlacementPRICE SENSITIVE20/06/18 download Created with Sketch. 110.13KB
BOT Trading HaltPRICE SENSITIVE18/06/18 download Created with Sketch. 434.33KB
BOT Australian Ethics approval for Acne StudyPRICE SENSITIVE13/06/18 download Created with Sketch. 107.55KB
BOT BTX 1204 Atopic Dermatitis Study Results PresentationPRICE SENSITIVE07/06/18 download Created with Sketch. 804.09KB
BOT Botanix Announces Successful Atopic Dermatitis Study ResultsPRICE SENSITIVE06/06/18 download Created with Sketch. 138.5KB
BOT Trading HaltPRICE SENSITIVE05/06/18 download Created with Sketch. 281.47KB
BOT Presentation on Atopic Dermatitis MarketPRICE SENSITIVE23/05/18 download Created with Sketch. 801.83KB
BOT FDA Green Light for BTX 1503 Phase 2 StudyPRICE SENSITIVE08/05/18 download Created with Sketch. 108.88KB
BOT Appendix 4C - quarterlyPRICE SENSITIVE24/04/18 download Created with Sketch. 371.31KB
BOT Enrolment of BTX 1204 Atopic Dermatitis Study CompletedPRICE SENSITIVE09/04/18 download Created with Sketch. 131.02KB
BOT Half Yearly Report and AccountsPRICE SENSITIVE26/02/18 download Created with Sketch. 680.59KB
BOT Completion of PlacementPRICE SENSITIVE12/02/18 download Created with Sketch. 148.38KB
BOT Significantly Oversubscribed A$15m PlacementPRICE SENSITIVE05/02/18 download Created with Sketch. 138.07KB
BOT Trading HaltPRICE SENSITIVE01/02/18 download Created with Sketch. 325.12KB
BOT Appendix 4C - quarterlyPRICE SENSITIVE31/01/18 download Created with Sketch. 184.6KB
BOT Botanix Announces Successful Acne Study ResultsPRICE SENSITIVE29/01/18 download Created with Sketch. 138.55KB
BOT Trading HaltPRICE SENSITIVE24/01/18 download Created with Sketch. 303.29KB
BOT Botanix Receives A$1.6m R&D Tax Incentive RefundPRICE SENSITIVE16/01/18 download Created with Sketch. 100.73KB
BOT Botanix Completes Enrolment of BTX 1503 Acne Patient StudyPRICE SENSITIVE18/12/17 download Created with Sketch. 105.47KB
BOT New Antibacterial Results Support BTX 1503 Acne ProgramPRICE SENSITIVE05/12/17 download Created with Sketch. 152.99KB
BOT Botanix Enrols First Patients in Dermatitis StudyPRICE SENSITIVE23/11/17 download Created with Sketch. 106.02KB
BOT Appendix 4C - quarterlyPRICE SENSITIVE31/10/17 download Created with Sketch. 607.2KB
BOT Botanix Commences BTX 1204 Dermatitis Patient StudyPRICE SENSITIVE31/10/17 download Created with Sketch. 109.18KB
BOT FDA Clears Development Path for BTX 1503PRICE SENSITIVE09/10/17 download Created with Sketch. 108.76KB
BOT Preliminary Final ReportPRICE SENSITIVE30/08/17 download Created with Sketch. 891.86KB
BOT Botanix Commences BTX 1503 Acne Patient StudyPRICE SENSITIVE21/08/17 download Created with Sketch. 280.16KB
BOT Trading HaltPRICE SENSITIVE17/08/17 download Created with Sketch. 135.8KB
BOT Appendix 4C - quarterlyPRICE SENSITIVE31/07/17 download Created with Sketch. 326.76KB
BOT Botanix Completes Successful Phase 1 BTX 1503 Clinical StudyPRICE SENSITIVE03/07/17 download Created with Sketch. 414.79KB
BOT Trading HaltPRICE SENSITIVE30/06/17 download Created with Sketch. 574.2KB
BOT 12 Month Operational Review Highlights Significant ProgressPRICE SENSITIVE27/06/17 download Created with Sketch. 576.07KB
BOT Successful Pilot Study for BTX 1701 Facial CleanserPRICE SENSITIVE08/06/17 download Created with Sketch. 507.57KB
BOT Completion of Tranche 2 of Capital Raising PlacementPRICE SENSITIVE19/05/17 download Created with Sketch. 404.09KB
BOT Botanix Commences First Clinical Study for BTX 1503PRICE SENSITIVE08/05/17 download Created with Sketch. 487.7KB
BOT Appendix 4C - quarterlyPRICE SENSITIVE28/04/17 download Created with Sketch. 1.58MB
BOT Completion of the Tranche 1 PlacementPRICE SENSITIVE12/04/17 download Created with Sketch. 429.35KB
BOT Reinstatement to official quotationPRICE SENSITIVE05/04/17 download Created with Sketch. 273.25KB
BOT Botanix Raises A$7.4 Million in Oversubscribed PlacementPRICE SENSITIVE05/04/17 download Created with Sketch. 282.75KB
BOT Suspension from Official QuotationPRICE SENSITIVE04/04/17 download Created with Sketch. 567.17KB
BOT Trading HaltPRICE SENSITIVE31/03/17 download Created with Sketch. 671.99KB
BOT Botanix Receives Approval for Synthetic Cannabidiol TrialPRICE SENSITIVE30/03/17 download Created with Sketch. 387.64KB
BOT Export and Import Approvals for Clinical Studies ReceivedPRICE SENSITIVE24/03/17 download Created with Sketch. 95.57KB
BOT Response to ASX Price QueryPRICE SENSITIVE13/03/17 download Created with Sketch. 494.35KB
BOT Half Yearly Report and AccountsPRICE SENSITIVE28/02/17 download Created with Sketch. 1.62MB
BOT Botanix Announces Filing of New Permetrex Product PatentsPRICE SENSITIVE27/02/17 download Created with Sketch. 95.48KB
BOT New Antimicrobial Data and Conference Presentation
08/09/20PRICE SENSITIVE download Created with Sketch. 1.73MB
BOT Appendix 4E and Annual Report to Shareholders
31/08/20PRICE SENSITIVE download Created with Sketch. 1.01MB
BOT BTX 1801 Phase 2a Antimicrobial Study Underway
12/08/20PRICE SENSITIVE download Created with Sketch. 187.59KB
BOT Appendix 4C - Quarterly
30/07/20PRICE SENSITIVE download Created with Sketch. 326.32KB
BOT Response to ASX Aware Query
22/07/20PRICE SENSITIVE download Created with Sketch. 740.97KB
BOT BTX 1503 End of Phase 2 Milestone with FDA
17/07/20PRICE SENSITIVE download Created with Sketch. 160.69KB
BOT Appendix 4C - Quarterly
30/04/20PRICE SENSITIVE download Created with Sketch. 303.6KB
BOT FDA Grants BTX 1801 QIDP Designation Status
24/04/20PRICE SENSITIVE download Created with Sketch. 275.59KB
BOT Botanix Provides Update on Development Activities Amended
16/04/20PRICE SENSITIVE download Created with Sketch. 300.12KB
BOT Botanix Provides Update on Development Activities
16/04/20PRICE SENSITIVE download Created with Sketch. 243.29KB
BOT Botanix Announces Top Line BTX 1204 Atopic Dermatitis Data
25/03/20PRICE SENSITIVE download Created with Sketch. 218.13KB
BOT Trading Halt
24/03/20PRICE SENSITIVE download Created with Sketch. 215.48KB
BOT Antimicrobial Platform Update and Launch of BTX 1801 Study
13/03/20PRICE SENSITIVE download Created with Sketch. 5.77MB
BOT Half Yearly Report and Accounts
28/02/20PRICE SENSITIVE download Created with Sketch. 925.03KB
BOT Appendix 4C - Quarterly
31/01/20PRICE SENSITIVE download Created with Sketch. 380KB
BOT Botanix Initiates BTX 1702 Rosacea Study
09/12/19PRICE SENSITIVE download Created with Sketch. 160.86KB
BOT Botanix Announces De-scheduling of Synthetic CBD
25/11/19PRICE SENSITIVE download Created with Sketch. 505.76KB
BOT Appendix 4C - Quarterly
31/10/19PRICE SENSITIVE download Created with Sketch. 382.3KB
BOT Botanix Announces BTX 1503 Data and Progression to Phase 3
22/10/19PRICE SENSITIVE download Created with Sketch. 739.31KB
BOT Trading Halt
22/10/19PRICE SENSITIVE download Created with Sketch. 359.17KB
BOT BOT Receives Grant for Synthetic Cannabidiol Analog Program
15/10/19PRICE SENSITIVE download Created with Sketch. 722.19KB
BOT Botanix announces new clinical program to target rosacea
16/09/19PRICE SENSITIVE download Created with Sketch. 898.27KB
BOT Appendix 4E and Annual Report
20/08/19PRICE SENSITIVE download Created with Sketch. 1022.01KB
BOT Botanix $40 Million US Lead Placement and Management Update
01/08/19PRICE SENSITIVE download Created with Sketch. 193.2KB
BOT Appendix 4C - Quarterly
31/07/19PRICE SENSITIVE download Created with Sketch. 397.02KB
BOT Trading Halt
30/07/19PRICE SENSITIVE download Created with Sketch. 360.81KB
BOT Botanix Antimicrobial Platform Addresses Global Threat
15/07/19PRICE SENSITIVE download Created with Sketch. 271.04KB
BOT BTX 1801 Kills Superbugs Without Resistance World-First
20/06/19PRICE SENSITIVE download Created with Sketch. 229.76KB
BOT Study Confirms Anti-inflammatory and Other Properties of CBD
19/06/19PRICE SENSITIVE download Created with Sketch. 866.27KB
BOT Trading Halt
18/06/19PRICE SENSITIVE download Created with Sketch. 242.68KB
BOT Pause in Trade
18/06/19PRICE SENSITIVE download Created with Sketch. 118.21KB
BOT Dermatology Industry Leader Joins Botanix
20/05/19PRICE SENSITIVE download Created with Sketch. 504.05KB
BOT Botanix Provides Retraction in Presentation
16/05/19PRICE SENSITIVE download Created with Sketch. 470.8KB
BOT Trading Halt
16/05/19PRICE SENSITIVE download Created with Sketch. 242.55KB
BOT Pause In Trading
16/05/19PRICE SENSITIVE download Created with Sketch. 117.85KB
BOT Appendix 4C - Quarterly
30/04/19PRICE SENSITIVE download Created with Sketch. 375.19KB
BOT Half Yearly Report and Accounts
28/02/19PRICE SENSITIVE download Created with Sketch. 390.01KB
BOT Permetrex Outperforms Other CBD Topical Products
26/02/19PRICE SENSITIVE download Created with Sketch. 8.72MB
BOT Appendix 4C - Quarterly
31/01/19PRICE SENSITIVE download Created with Sketch. 839.2KB
BOT Investigators Meeting Completed for BTX 1204 Phase 2 Study
25/01/19PRICE SENSITIVE download Created with Sketch. 178.7KB
BOT Ethics Approval for Phase 2 Atopic Dermatitis Study Received
18/12/18PRICE SENSITIVE download Created with Sketch. 177.02KB
BOT Botanix receives A$4.6m R&D Tax Incentive refund
23/11/18PRICE SENSITIVE download Created with Sketch. 151.28KB
BOT First Patient Treated in BTX 1308 Psoriasis Patient Study
07/11/18PRICE SENSITIVE download Created with Sketch. 197.52KB
BOT Appendix 4C - Quarterly
31/10/18PRICE SENSITIVE download Created with Sketch. 350.81KB
BOT Ethics Approval for BTX 1308 Psoriasis Patient Study Secured
27/09/18PRICE SENSITIVE download Created with Sketch. 106.68KB
BOT Botanix BTX 1503 Clinical Trial Update
12/09/18PRICE SENSITIVE download Created with Sketch. 151.01KB
BOT Pause in trading
12/09/18PRICE SENSITIVE download Created with Sketch. 117.1KB
BOT Preliminary Final Report
31/08/18PRICE SENSITIVE download Created with Sketch. 258.87KB
BOT FDA Clears Development Path for BTX 1204
30/08/18PRICE SENSITIVE download Created with Sketch. 131.96KB
BOT Appendix 4C - Quarterly
31/07/18PRICE SENSITIVE download Created with Sketch. 590.1KB
BOT Investigators Meeting Completed for BTX 1503 Phase 2 Trial
23/07/18PRICE SENSITIVE download Created with Sketch. 111.27KB
BOT Botanix Joins with UQ to Accelerate Development of BTX 1801
19/07/18PRICE SENSITIVE download Created with Sketch. 207.21KB
BOT Botanix update on development pipeline products
02/07/18PRICE SENSITIVE download Created with Sketch. 937.48KB
BOT First Patients Recruited into BTX 1503 Phase 2 Acne Trial
27/06/18PRICE SENSITIVE download Created with Sketch. 110.99KB
BOT BOT Welcomes First FDA Approval for Cannabidiol Product
26/06/18PRICE SENSITIVE download Created with Sketch. 139.87KB
BOT Botanix Raises A$8m in Oversubscribed Placement
20/06/18PRICE SENSITIVE download Created with Sketch. 110.13KB
BOT Trading Halt
18/06/18PRICE SENSITIVE download Created with Sketch. 434.33KB
BOT Australian Ethics approval for Acne Study
13/06/18PRICE SENSITIVE download Created with Sketch. 107.55KB
BOT BTX 1204 Atopic Dermatitis Study Results Presentation
07/06/18PRICE SENSITIVE download Created with Sketch. 804.09KB
BOT Botanix Announces Successful Atopic Dermatitis Study Results
06/06/18PRICE SENSITIVE download Created with Sketch. 138.5KB
BOT Trading Halt
05/06/18PRICE SENSITIVE download Created with Sketch. 281.47KB
BOT Presentation on Atopic Dermatitis Market
23/05/18PRICE SENSITIVE download Created with Sketch. 801.83KB
BOT FDA Green Light for BTX 1503 Phase 2 Study
08/05/18PRICE SENSITIVE download Created with Sketch. 108.88KB
BOT Appendix 4C - quarterly
24/04/18PRICE SENSITIVE download Created with Sketch. 371.31KB
BOT Enrolment of BTX 1204 Atopic Dermatitis Study Completed
09/04/18PRICE SENSITIVE download Created with Sketch. 131.02KB
BOT Half Yearly Report and Accounts
26/02/18PRICE SENSITIVE download Created with Sketch. 680.59KB
BOT Completion of Placement
12/02/18PRICE SENSITIVE download Created with Sketch. 148.38KB
BOT Significantly Oversubscribed A$15m Placement
05/02/18PRICE SENSITIVE download Created with Sketch. 138.07KB
BOT Trading Halt
01/02/18PRICE SENSITIVE download Created with Sketch. 325.12KB
BOT Appendix 4C - quarterly
31/01/18PRICE SENSITIVE download Created with Sketch. 184.6KB
BOT Botanix Announces Successful Acne Study Results
29/01/18PRICE SENSITIVE download Created with Sketch. 138.55KB
BOT Trading Halt
24/01/18PRICE SENSITIVE download Created with Sketch. 303.29KB
BOT Botanix Receives A$1.6m R&D Tax Incentive Refund
16/01/18PRICE SENSITIVE download Created with Sketch. 100.73KB
BOT Botanix Completes Enrolment of BTX 1503 Acne Patient Study
18/12/17PRICE SENSITIVE download Created with Sketch. 105.47KB
BOT New Antibacterial Results Support BTX 1503 Acne Program
05/12/17PRICE SENSITIVE download Created with Sketch. 152.99KB
BOT Botanix Enrols First Patients in Dermatitis Study
23/11/17PRICE SENSITIVE download Created with Sketch. 106.02KB
BOT Appendix 4C - quarterly
31/10/17PRICE SENSITIVE download Created with Sketch. 607.2KB
BOT Botanix Commences BTX 1204 Dermatitis Patient Study
31/10/17PRICE SENSITIVE download Created with Sketch. 109.18KB
BOT FDA Clears Development Path for BTX 1503
09/10/17PRICE SENSITIVE download Created with Sketch. 108.76KB
BOT Preliminary Final Report
30/08/17PRICE SENSITIVE download Created with Sketch. 891.86KB
BOT Botanix Commences BTX 1503 Acne Patient Study
21/08/17PRICE SENSITIVE download Created with Sketch. 280.16KB
BOT Trading Halt
17/08/17PRICE SENSITIVE download Created with Sketch. 135.8KB
BOT Appendix 4C - quarterly
31/07/17PRICE SENSITIVE download Created with Sketch. 326.76KB
BOT Botanix Completes Successful Phase 1 BTX 1503 Clinical Study
03/07/17PRICE SENSITIVE download Created with Sketch. 414.79KB
BOT Trading Halt
30/06/17PRICE SENSITIVE download Created with Sketch. 574.2KB
BOT 12 Month Operational Review Highlights Significant Progress
27/06/17PRICE SENSITIVE download Created with Sketch. 576.07KB
BOT Successful Pilot Study for BTX 1701 Facial Cleanser
08/06/17PRICE SENSITIVE download Created with Sketch. 507.57KB
BOT Completion of Tranche 2 of Capital Raising Placement
19/05/17PRICE SENSITIVE download Created with Sketch. 404.09KB
BOT Botanix Commences First Clinical Study for BTX 1503
08/05/17PRICE SENSITIVE download Created with Sketch. 487.7KB
BOT Appendix 4C - quarterly
28/04/17PRICE SENSITIVE download Created with Sketch. 1.58MB
BOT Completion of the Tranche 1 Placement
12/04/17PRICE SENSITIVE download Created with Sketch. 429.35KB
BOT Reinstatement to official quotation
05/04/17PRICE SENSITIVE download Created with Sketch. 273.25KB
BOT Botanix Raises A$7.4 Million in Oversubscribed Placement
05/04/17PRICE SENSITIVE download Created with Sketch. 282.75KB
BOT Suspension from Official Quotation
04/04/17PRICE SENSITIVE download Created with Sketch. 567.17KB
BOT Trading Halt
31/03/17PRICE SENSITIVE download Created with Sketch. 671.99KB
BOT Botanix Receives Approval for Synthetic Cannabidiol Trial
30/03/17PRICE SENSITIVE download Created with Sketch. 387.64KB
BOT Export and Import Approvals for Clinical Studies Received
24/03/17PRICE SENSITIVE download Created with Sketch. 95.57KB
BOT Response to ASX Price Query
13/03/17PRICE SENSITIVE download Created with Sketch. 494.35KB
BOT Half Yearly Report and Accounts
28/02/17PRICE SENSITIVE download Created with Sketch. 1.62MB
BOT Botanix Announces Filing of New Permetrex Product Patents
27/02/17PRICE SENSITIVE download Created with Sketch. 95.48KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
14.8¢
Change
-0.003(1.67%)
Mkt cap ! $289.2M
Open High Low Value Volume
15.0¢ 15.3¢ 14.0¢ $1.107M 7.571M

Buyers (Bids)

No. Vol. Price($)
38 2934284 14.5¢
 

Sellers (Offers)

Price($) Vol. No.
15.0¢ 1210708 16
View Market Depth
Last trade - 11.09am 01/08/2025 (20 minute delay) ?
Last
14.8¢
  Change
-0.003 ( 2.51 %)
Open High Low Volume
15.0¢ 15.0¢ 14.3¢ 4652676
Last updated 11.19am 01/08/2025 ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.